VIVET ATTENDING 3RD ANNUAL GENE THERAPY FOR RARE DISORDERS CONFERENCE IN BOSTON

VIVET ATTENDING 3RD ANNUAL GENE THERAPY FOR RARE DISORDERS CONFERENCE IN BOSTON

Jean-Philippe Combal, Vivet Therapeutics’ CEO, will be attending the 3rd Annual Gene Therapy for Rare Disorders conference in Boston (March 26-28 2019).

Latest events

Vivet Therapeutics is heading west for The Liver Meeting in sunny ☀ San Diego, California!

14 November 2024

🎉 Vivet Therapeutics is heading to Stockholm for BIO-Europe! 🎉

4 November 2024

Australasian Gene & Cell Therapy Biennial Meeting

28 October 2024

Inaugural Cell & Gene Therapy Regulatory Affairs Summit presented by @HansonWade, from 28 – 30 October in 🏦 Washington, D.C.!

24 October 2024

Who’s excited about the @World Orphan Drug Congress Europe 2024🌍taking place in Spain from 22-25 October?

17 October 2024

🎓Are you attending the upcoming 2024 @European Society of Gene and Cell Therapy (#ESGCT) Congress, from 22-25 October in Rome, Italy?

17 October 2024